Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection

J Infect Dis. 1997 Dec;176(6):1496-500. doi: 10.1086/514147.

Abstract

This article describes a prospective longitudinal study of varicella-zoster virus (VZV) infections in human immunodeficiency virus (HIV)-infected children, designed to determine their natural history of VZV infection and possible effects of VZV on the progression of HIV infection. Varicella was usually not a serious acute problem, and it did not seem to precede clinical deterioration. The rate of zoster was high: 70% in children with low levels of CD4+ lymphocytes at the time of development of varicella. It is predicted that immunization with live attenuated varicella vaccine is unlikely to be deleterious to HIV-infected children. Moreover, if they are immunized when they still have relatively normal levels of CD4+ lymphocytes, they may have a lower rate of reactivation of VZV than if they were allowed to develop natural varicella when their CD4+ cell counts have fallen to low levels as a result of progressive HIV infection.

Publication types

  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes / immunology
  • Case-Control Studies
  • Chickenpox / complications*
  • Chickenpox / prevention & control
  • Chickenpox Vaccine / adverse effects
  • Chickenpox Vaccine / immunology
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Herpes Zoster / complications*
  • Herpes Zoster / immunology
  • Herpes Zoster / virology
  • Herpesvirus 3, Human / immunology
  • Humans
  • Male
  • New York
  • Prospective Studies

Substances

  • Antibodies, Viral
  • Chickenpox Vaccine